Sexually transmitted diseases in animals: ecological and evolutionary implications.

AB Lockhart, PH Thrall, J Antonovics - Biological Reviews of the …, 1996 - europepmc.org
Sexually transmitted diseases (STDs) have been generally thought of as a small subset of
infectious diseases, rather than as an important group of diseases that occur in numerous …

Pharmacogenetics of ATP-binding cassette transporters in cancer and chemotherapy

AC Lockhart, RG Tirona, RB Kim - Molecular cancer therapeutics, 2003 - AACR
The ATP-binding cassette (ABC) transporters belong to the largest known transporter gene
family and translocate a variety of substrates including chemotherapy agents. ABC multidrug …

[PDF][PDF] Multi-institutional experience with FOLFIRINOX in pancreatic adenocarcinoma

…, BR Tan, J Picus, SM Sorscher, R Suresh, AC Lockhart… - 2012 - digitalcommons.wustl.edu
Context Combination chemotherapy with FOLFIRINOX (oxaliplatin, irinotecan, fluorouracil,
and leucovorin) was shown to be effective in a large phase III trial. Objective The purpose of …

Antimicrobials from human skin commensal bacteria protect against Staphylococcus aureus and are deficient in atopic dermatitis

…, AV Melnik, H Latif, JN Kim, A Lockhart… - Science translational …, 2017 - science.org
The microbiome can promote or disrupt human health by influencing both adaptive and
innate immune functions. We tested whether bacteria that normally reside on human skin …

Gastric cancer, version 3.2016, NCCN clinical practice guidelines in oncology

…, WM Korn, S Leong, C Linn, AC Lockhart… - Journal of the National …, 2016 - jnccn.org
Gastric cancer is the fifth most frequently diagnosed cancer and the third leading cause of
death from cancer in the world. Several advances have been made in the staging procedures, …

HER kinase inhibition in patients with HER2-and HER3-mutant cancers

…, IA Mayer, V Boni, E Calvo, S Loi, AC Lockhart… - Nature, 2018 - nature.com
Somatic mutations of ERBB2 and ERBB3 (which encode HER2 and HER3, respectively)
are found in a wide range of cancers. Preclinical modelling suggests that a subset of these …

Gastric cancer, version 2.2013

…, LR Kleinberg, WM Korn, AC Lockhart… - Journal of the national …, 2013 - jnccn.org
The NCCN Clinical Practice Guidelines in Oncology for Gastric Cancer provide evidence-and
consensus-based recommendations for a multidisciplinary approach for the management …

Efficacy and safety of pembrolizumab for heavily pretreated patients with advanced, metastatic adenocarcinoma or squamous cell carcinoma of the esophagus: the …

…, SB Kim, M Tajika, HT Kim, AC Lockhart… - JAMA …, 2019 - jamanetwork.com
Importance Effective treatment options are limited for patients with advanced, metastatic
esophageal cancer progressing after 2 or more lines of systemic therapy. Objective To evaluate …

Esophageal and esophagogastric junction cancers, version 1.2015

…, LR Kleinberg, WM Korn, S Leong, AC Lockhart… - Journal of the National …, 2015 - jnccn.org
Esophageal cancer is the sixth most common cause of cancer deaths worldwide.
Adenocarcinoma is more common in North America and Western European countries, originating …

Vemurafenib for BRAF V600–mutant Erdheim-Chester disease and Langerhans cell histiocytosis: analysis of data from the histology-independent, phase 2, open …

EL Diamond, V Subbiah, AC Lockhart, JY Blay… - JAMA …, 2018 - jamanetwork.com
Importance The histiocytic neoplasms Erdheim-Chester disease (ECD) and Langerhans cell
histiocytosis (LCH) are highly enriched forBRAFV600 mutations and have been previously …